DalsnaFinance › IPOs › Veraxa Biotech › IPO
Veraxa Biotech AG completed its initial public offering on Nasdaq on June 9, 2026.
| Ticker | VRXA |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | June 9, 2026 |
| Sector | Pharmaceutical Preparations |
Veraxa Biotech AG listed on Nasdaq on 2026-06-09.
Ingested from SEC EDGAR (8-A12B, 8-A12B/A), CIK 2079109.
Veraxa Biotech AG — quote, profile and latest news →
Source: SEC EDGAR filings for Veraxa Biotech AG. This page is general information, not investment advice.